ADP101 multifood oral immunotherapy for food-allergic patients: Harmony phase 1/2 randomized clinical trial.

Kim EH, Carr WW, Assa'ad AH, Gogate SU, Petroni DH, Casale TB, Wang ML, Sullivan A, Archer AM, Wang O, Piscia-Nichols C, Tuomi L, Levin-Young O, Dombkowski A, McClintock D, Harmony investigators

Open source

DOI
10.1016/j.jacig.2024.100382
Published
2025 Feb
Container
The journal of allergy and clinical immunology. Global
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacig.2024.100382,
  title = {ADP101 multifood oral immunotherapy for food-allergic patients: Harmony phase 1/2 randomized clinical trial.},
  author = {Kim EH and Carr WW and Assa'ad AH and Gogate SU and Petroni DH and Casale TB and Wang ML and Sullivan A and Archer AM and Wang O and Piscia-Nichols C and Tuomi L and Levin-Young O and Dombkowski A and McClintock D and Harmony investigators},
  year = {2025},
  journal = {The journal of allergy and clinical immunology. Global},
  doi = {10.1016/j.jacig.2024.100382},
  url = {https://doi.org/10.1016/j.jacig.2024.100382}
}

RIS

TY  - JOUR
TI  - ADP101 multifood oral immunotherapy for food-allergic patients: Harmony phase 1/2 randomized clinical trial.
AU  - Kim EH
AU  - Carr WW
AU  - Assa'ad AH
AU  - Gogate SU
AU  - Petroni DH
AU  - Casale TB
AU  - Wang ML
AU  - Sullivan A
AU  - Archer AM
AU  - Wang O
AU  - Piscia-Nichols C
AU  - Tuomi L
AU  - Levin-Young O
AU  - Dombkowski A
AU  - McClintock D
AU  - Harmony investigators
PY  - 2025
JO  - The journal of allergy and clinical immunology. Global
DO  - 10.1016/j.jacig.2024.100382
UR  - https://doi.org/10.1016/j.jacig.2024.100382
ER  - 

APA

EH, K., WW, C., AH, A., SU, G., DH, P., TB, C., ML, W., A, S., AM, A., O, W., C, P., L, T., O, L., A, D., D, M., & investigators, H. (2025). ADP101 multifood oral immunotherapy for food-allergic patients: Harmony phase 1/2 randomized clinical trial.. The journal of allergy and clinical immunology. Global. https://doi.org/10.1016/j.jacig.2024.100382

Source records